[ad_1]
BioNTech, a German manufacturer of the COVID-19 vaccine, predicts that existing technology can be used. A new vaccine was produced to combat the new strain of COVID in 6 weeks.
BioNTech CEO Ugur Sahin said he believes the company can use the existing COVID-19 vaccine, developed with Pfizer, to produce a vaccine that will continue to be effective against COVID-19. New species. He said it was the beauty of mRNA technology that could produce new vaccines.
Scientists will be able to understand the new emerging vaccine by separating England from the rest of the country. As many countries have tried to suspend travel Avoid traveling to and from England. Or suspend the transport of goods More than 40 countries have banned travel.
After the British found a new strain of COVID in late September. The virus has spread so rapidly that five countries now have new strains of COVID, including Denmark, Iceland, the Netherlands, Australia and Italy, although British authorities have warned that the new strain of COVID is easier to infect, Dr. Ugur. That the vaccine produced today resists And if it is necessary to produce a new vaccine, it can be done in 6 weeks.
However, Dr. Sahin maintains that scientists are not optimistic. But I think things are similar, they can work quite well with each other. Although the new virus has some changes. But there are many parts of the virus that have not changed much. This includes immunity associated with vaccination. Fighting infections like T cells (a specific immune system He said would have to ensure them that T cells respond. That needs to be tested in large enough quantities to see if it still works or not
Dr. Sahin said that laboratory tests could take at least two weeks. To demonstrate that the approved BioNTech / Pfizer vaccine will work well in England. US and EU?
Additionally, Ozlem Tureci, bioNTech chief of medicine, said that the mRNA technology used to develop the vaccine should facilitate the development of vaccines for new strains of COVID. Of which vaccines BioNTech / Pfizer has been approved by the European Medicines Agency (European Medicines Agency) after many countries began to adopt, such as United Kingdom, United States.
Joe Biden said that the new leader of the United States had just been vaccinated from Pfizer / BioNTech took the first dose. He received the first dose of the vaccine after being vaccinated to healthcare workers one day after the US Food and Drug Administration approved the emergency vaccine.
Today I received the COVID-19 vaccine.
To the scientists and researchers who worked tirelessly to make this possible, thank you. We owe them a lot.
And for the American people, know that there is nothing to worry about. When the vaccine is available, I urge you to take it. pic.twitter.com/QBtB620i2V
– Joe Biden (@JoeBiden) December 22, 2020
The company is likely to start distributing the drug to the European Union on December 26. The vaccine will begin shipping to the UK, the US, Canada and Israel. BioNTech will deliver 45 million doses of the vaccine by the end of the year. That includes 12.5 million doses from the EU, 20 million doses of the vaccine. The company aims to produce around 1.3 billion doses of the vaccine by the end of 2021.
Source: Financial Times, CNN, NPR
Follow the Brand Inside news from our Facebook.
Related
[ad_2]
